Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

162 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study.
Komeda T, Takazono T, Hosogaya N, Miyazaki T, Ogura E, Iwata S, Miyauchi H, Honda K, Fujiwara M, Ajisawa Y, Watanabe H, Kitanishi Y, Hara K, Mukae H. Komeda T, et al. Clin Infect Dis. 2021 Sep 7;73(5):e1181-e1190. doi: 10.1093/cid/ciaa1870. Clin Infect Dis. 2021. PMID: 33354728 Free PMC article.
Reply to Shirata et al.
Komeda T, Takazono T, Hosogaya N, Ogura E, Miyauchi H, Iwata S, Mukae H. Komeda T, et al. Clin Infect Dis. 2021 Oct 5;73(7):e1766-e1767. doi: 10.1093/cid/ciaa1923. Clin Infect Dis. 2021. PMID: 33386407 No abstract available.
Comparison of the incidence of bleeding between baloxavir marboxil and other anti-influenza drugs among outpatients with influenza virus infection: A retrospective cohort study using an employment-based health insurance claims database in Japan.
Hara A, Hara K, Komeda T, Ogura E, Miyazawa S, Kobayashi C, Fujiwara M, Yoshida M, Urushihara H. Hara A, et al. Among authors: komeda t. Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):623-631. doi: 10.1002/pds.5392. Epub 2021 Dec 23. Pharmacoepidemiol Drug Saf. 2022. PMID: 34881477 Free PMC article.
Letter to the Editor regarding Response to "Letter to Editor: "Real-World Effectiveness of Ensitrelvir in Reducing Severe Outcomes in Outpatients at High Risk for COVID-19".
Takazono T, Fujita S, Komeda T, Miyazawa S, Yoshida Y, Kitanishi Y, Kinoshita M, Kojima S, Shen H, Uehara T, Hosogaya N, Iwanaga N, Mukae H. Takazono T, et al. Among authors: komeda t. Infect Dis Ther. 2024 Nov;13(11):2463-2467. doi: 10.1007/s40121-024-01054-6. Epub 2024 Sep 27. Infect Dis Ther. 2024. PMID: 39331323 Free PMC article. No abstract available.
162 results